Hikal Ltd share price inched up 1.78% to Rs 232.15. The Company's net profit tanked by 151.39% to Rs 7.4 crore, while revenue from operations plunged by 22.67% to Rs 399.8 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.84 lakh crore, gaining 5.02%. It has improved by 1.03% over last one week and rose by 11.63% in last one month while the market capitalization of Hikal Ltd has marginally improved by 7.13% and 10.08% in the same period respectively. Profit before tax (PBT) of Hikal Ltd stood at Rs 9.9 crore in Q2 FY26, tumbling by 67.43% year-on-year, and plunging by 219.28% quarter-on-quarter. EBITDA came in at Rs 35 crore, rallying 46.06% YoY and crashing by 64.37% sequentially. Total expenses reduced by 10.42% to Rs 408.5 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 194.0 crore, marginally falling by 7.75% YoY, while employee benefits expense was at Rs 74.4 crore, registering a growth of 10.71% YoY. For the TTM ended FY26, revenue from operations inched higher 4.23% to Rs 1843.5 crore, while net profit soared by 30.46% to Rs 90.8 crore, compared to previous TTM. EBITDA surged by 28030% to Rs 323.4 crore, and PBT soared 29.63% to Rs 123.8 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 280.4 crore in FY26, as against Rs 186.72 crore in FY25. Hikal Ltd crashed 26.31% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.64% during the same period.
